This Is MS Multiple Sclerosis Community: Knowledge & Support

Novartis announced today that the Phase III INFORMS study in primary progressive multiple sclerosis (PPMS) did not show a significant difference between fingolimod and placebo on a combination of disability measures. The safety results were consistent with the well-characterized safety profile of fingolimod in relapsing MS (RMS)....... Read more - http://www.ms-uk.org/gilenya

SMC first to introduce oral Gilenya® as a first line treatment option for people with a severe form of MS

• Scottish people with a severe form of relapsing remitting multiple sclerosis are first in UK to get access to once daily pill fingolimod as a first line treatment option1
• Once daily pill fingolimod reduces the risk of relapses by 67% compared to placebo

Today, the Scottish Medicines Consortium (SMC) has accepted once daily ...

Gilenya in new therapeutic indication: Added benefit not proven

The immunosuppressive drug fingolimod (trade name: Gilenya) was approved for an expanded therapeutic indication in May 2014: It is now also available for adults with highly active relapsing remitting multiple sclerosis (RRMS) who had received other pretreatment than interferon beta (IFN-β). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and ...

I have been taking Gilenya since March 2013 and after 9 years on Betaferon it's been brilliant. However this year it seems like the side effects have started to kick in. Around Easter 2014 I started experiencing low back pain, but only when I am lying down to sleep. Some nights are ok, but other nights it's really painful. When it is bad I find it very difficult to turn over and even if I ...

The European Commission has endorsed the recent Committee for Medicinal Products for Human Use (CHMP) positive opinion recommending the expanded use of Swiss drug major Novartis’ drug Gilenya (fingolimod) for adult patients with highly active relapsing-remitting multiple sclerosis (RRMS)..... Read More - http://www.ms-uk.org/gilenya

Well I have been on a Gilenya for 3 months.
No flares or anything. Easiest med I have been on for MS.
My neuro wants 1st blood work between 3 & 4 months.
How often is blood work typically done?

Novartis International AG ( NVS ) announced new data showing that more patients with relapsing multiple sclerosis treated with Gilenya (fingolimod) achieved an average annual rate of brain volume loss within the range of those expected for healthy adults of a similar age vs. those patients taking placebo. People with multiple sclerosis experience shrinkage of the brain up to three to five times faster. This acceleration starts early in people with relapsing MS, even before ...

CHMP issues positive opinion to expand EU label for Gilenya in RRMS

Swiss drug giant Novartis said that the Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion to expand the EU label for Gilenya (fingolimod) in relapsing remitting multiple sclerosis or RRMS..... Read More - http://www.ms-uk.org/gilenya

Hi,

I'm a diagnosed MS patient for around 7 years or so. I've been taking Interferon B1a, first 44mu and now 22mu throughout all this time.

Around a week ago I discovered I had another relapse and the doctor recommended me to start with Fingolimod. But the first thing I did after that was checking Wikipedia and got to this quote:

Fingolimod has also been reported to be a cannabinoid receptor antagonist

Does that mean ...

Hi -
I just started taking Gilenya a month ago, and thought I had developed a UTI. Cultures are negative, but I have been using the bathroom at least twice an hour over the past several days. Definitely worse shortly after I take my meds, and dissipates before I am ready for my next dosage. Has anyone else experienced this, and if so, how did you manage it? I'm happy with Gilenya otherwise....